Untold story of human cervical cancers: HPV-negative cervical cancer |
Lee, Jae-Eun
(Department of Biomedical Science, University of Sheffield)
Chung, Yein (St. Benedict Catholic Secondary School) Rhee, Siyeon (Stanford Cardiovascular Institute, Stanford University School of Medicine) Kim, Tae-Hyung (Department of Pathology, University of New Mexico School of Medicine) |
1 | Chaudary N, Jaluba K, Pintilie M and Hill RP (2015) Establishment of orthotopic primary cervix cancer xenografts. Methods Mol Biol 1249, 381-391 DOI |
2 | Roman M, Baraibar I, Lopez I et al (2018) KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target. Mol Cancer 17, 33 |
3 | Pirog EC (2017) Cervical adenocarcinoma: diagnosis of human papillomavirus-positive and human papillomavirusnegative tumors. Arch Pathol Lab Med 141, 1653-1667 DOI |
4 | Chumduri C, Gurumurthy RK, Berger H et al (2021) Opposing Wnt signals regulate cervical squamocolumnar homeostasis and emergence of metaplasia. Nat Cell Biol 23, 184-197 DOI |
5 | Lohmussaar K, Oka R, Espejo Valle-Inclan J et al (2021) Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer. Cell Stem Cell 28, 1380-1396 e1386 |
6 | Li C, Zhou T, Chen J et al (2022) The role of Exosomal miRNAs in cancer. J Transl Med 20, 6 |
7 | Bhat A, Yadav J, Thakur K et al (2022) Transcriptome analysis of cervical cancer exosomes and detection of HPVE6*I transcripts in exosomal RNA. BMC Cancer 22, 164 |
8 | Bhat A, Yadav J, Thakur K et al (2021) Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog-GLI signaling components. Cancer Cell Int 21, 319 |
9 | Zhang Y, Liu Y, Liu H and Tang WH (2019) Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci 9, 19 |
10 | Durst M, Gissmann L, Ikenberg H and zur Hausen H (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 80, 3812-3815 DOI |
11 | Petry KU, Liebrich C, Luyten A, Zander M and Iftner T (2017) Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers. Papillomavirus Res 4, 85-89 DOI |
12 | Baay MF, Tjalma WA, Weyler J et al (2001) Prevalence of human papillomavirus in elderly women with cervical cancer. Gynecol Obstet Invest 52, 248-251 DOI |
13 | Zampronha Rde A, Freitas-Junior R, Murta EF et al (2013) Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer. Clinics (Sao Paulo) 68, 809-814 DOI |
14 | Sharma RK, Srivastava AK, Yolcu ES et al (2010) SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model. Vaccine 28, 5794-5802 DOI |
15 | Immel TA, Grutzke M, Spate AK, Groth U, Ohlschlager P and Huhn T (2012) Synthesis and X-ray structure analysis of a heptacoordinate titanium(IV)-bis-chelate with enhanced in vivo antitumor efficacy. Chem Commun (Camb) 48, 5790-5792 DOI |
16 | Poljak M, Cuzick J, Kocjan BJ, Iftner T, Dillner J and Arbyn M (2012) Nucleic acid tests for the detection of alpha human papillomaviruses. Vaccine 30 Suppl 5, F100-106 DOI |
17 | Colombo N, Dubot C, Lorusso D et al (2021) Pembrolizumab for persistent, recurrent, or metastatic cervical cancer. N Engl J Med 385,1856-1867 DOI |
18 | Bonaventura P, Shekarian T, Alcazer V et al (2019) Cold tumors: a therapeutic challenge for immunotherapy. Front Immunol 10, 168 |
19 | Shimada M, Tokunaga H, Kigawa J and Yaegashi N (2020) Impact of histopathological risk factors on the treatment of stage IB-IIB uterine cervical cancer. Tohoku J Exp Med 252, 339-351 DOI |
20 | Meijer CJ, Berkhof J, Castle PE et al (2009) Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 124, 516-520 DOI |
21 | Prigge ES, Arbyn M, von Knebel Doeberitz M and Reuschenbach M (2017) Diagnostic accuracy of p16(INK4a) immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis. Int J Cancer 140, 1186-1198 DOI |
22 | Klaes R, Friedrich T, Spitkovsky D et al (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92, 276-284 DOI |
23 | Larque AB, Hakim S, Ordi J et al (2014) High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas. Mod Pathol 27, 343-351 DOI |
24 | Alos L, Moyano S, Nadal A et al (2009) Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer 115, 2701-2709 DOI |
25 | Zhang J, Liu SC, Luo XH et al (2016) Exosomal long noncoding RNAs are differentially expressed in the cervicovaginal lavage samples of cervical cancer patients. J Clin Lab Anal 30, 1116-1121 DOI |
26 | Thery C, Zitvogel L and Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2, 569-579 DOI |
27 | Romero-Pastrana F (2012) Detection and typing of human papilloma virus by multiplex PCR with type-specific primers. ISRN Microbiol 2012, 186915 |
28 | Pratili MA, Le Doussal V, Harvey P et al (1986) [Human papillomaviruses in the epithelial cells of the cervix uteri: frequency of types 16 and 18. Preliminary results of a clinical, cytologic and viral study]. J Gynecol Obstet Biol Reprod (Paris) 15, 45-50 |
29 | Iftner T, Germ L, Swoyer R et al (2009) Study comparing human papillomavirus (HPV) real-time multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV genotyping PCR assays. J Clin Microbiol 47, 2106-2113 DOI |
30 | Jarrom D, Elston L, Washington J et al (2022) Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review. BMJ Evid Based Med 27, 33-45 DOI |
31 | Weisbrod CR, Chavez JD, Eng JK, Yang L, Zheng C and Bruce JE (2013) In vivo protein interaction network identified with a novel real-time cross-linked peptide identification strategy. J Proteome Res 12, 1569-1579 DOI |
32 | Barreto CL, Martins DB, de Lima Filho JL and Magalhaes V (2013) Detection of human papillomavirus in biopsies of patients with cervical cancer, and its association with prognosis. Arch Gynecol Obstet 288, 643-648 DOI |
33 | Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE and Burrell CJ (1991) Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 338, 910-913 DOI |
34 | Chung HC, Ros W, Delord JP et al (2019) Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol 37, 1470-1478 DOI |
35 | Marth C, Landoni F, Mahner S et al (2017) Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28, iv72-iv83 DOI |
36 | Wendel Naumann R and Leath CA 3rd (2020) Advances in immunotherapy for cervical cancer. Curr Opin Oncol 32, 481-487 DOI |
37 | Stolnicu S, Barsan I, Hoang L et al (2018) International Endocervical Adenocarcinoma Criteria and Classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol 42, 214-226 DOI |
38 | Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P and Olivier M (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26, 2157-2165 DOI |
39 | Yeung AR, Pugh SL, Klopp AH et al (2020) Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: a report from the NRG Oncology RTOG 1203 Study. J Clin Oncol 38, 1685-1692 DOI |
40 | Barlesi F, Scherpereel A, Gorbunova V et al (2014) Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial. Ann Oncol 25, 1044-1052 DOI |
41 | Woodman CB, Collins SI and Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7, 11-22 DOI |
42 | Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V and Orth G (1990) Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 335, 1171-1174 DOI |
43 | Reed N, Balega J, Barwick T et al (2021) British Gynaecological Cancer Society (BGCS) cervical cancer guidelines: recommendations for practice. Eur J Obstet Gynecol Reprod Biol 256, 433-465 DOI |
44 | Arezzo F, Cormio G, Loizzi V et al (2021) HPV-negative cervical cancer: a narrative review. Diagnostics (Basel) 11, 952 |
45 | Yetkin-Arik B, Kastelein AW, Klaassen I et al (2021) Angiogenesis in gynecological cancers and the options for antiangiogenesis therapy. Biochim Biophys Acta Rev Cancer 1875, 188446 |
46 | Mezache L, Paniccia B, Nyinawabera A and Nuovo GJ (2015) Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers. Mod Pathol 28, 1594-1602 DOI |
47 | Da Silva DM, Enserro DM, Mayadev JS et al (2020) Immune activation in patients with locally advanced cervical cancer treated with ipilimumab following definitive chemoradiation (GOG-9929). Clin Cancer Res 26, 5621-5630 DOI |
48 | Gheit T, Landi S, Gemignani F et al (2006) Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 44, 2025-2031 DOI |
49 | Jedpiyawongse A, Homcha-em P, Karalak A and Srivatanakul P (2008) Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand. Asian Pac J Cancer Prev 9, 625-630 |
50 | Cancer Genome Atlas Research N, Albert Einstein College of M, Analytical Biological S et al (2017) Integrated genomic and molecular characterization of cervical cancer. Nature 543, 378-384 DOI |
51 | Nicolas I, Marimon L, Barnadas E et al (2019) HPV-negative tumors of the uterine cervix. Mod Pathol 32, 1189-1196 DOI |
52 | Li P, Tan Y, Zhu LX et al (2017) Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis. Oncotarget 8, 66352-66359 DOI |
53 | Tjalma WA, Trinh XB, Rosenlund M et al (2015) A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium. Facts Views Vis Obgyn 7, 101-108 |
54 | Tommasino M, Accardi R, Caldeira S et al (2003) The role of TP53 in cervical carcinogenesis. Hum Mutat 21, 307-312 DOI |
55 | Pirog EC (2015) Diagnosis of HPV-negative, gastric-type adenocarcinoma of the endocervix. Methods Mol Biol 1249, 213-219 DOI |
56 | Arbeit JM (2003) Mouse models of cervical cancer. Comp Med 53, 256-258 |
57 | Rodriguez-Carunchio L, Soveral I, Steenbergen RD et al (2015) HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis. BJOG 122, 119-127 DOI |
58 | Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71, 209-249 DOI |
59 | Li N, Franceschi S, Howell-Jones R, Snijders PJ and Clifford GM (2011) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128, 927-935 DOI |
60 | Xing B, Guo J, Sheng Y, Wu G and Zhao Y (2020) Human papillomavirus-negative cervical cancer: a comprehensive review. Front Oncol 10, 606335 |
61 | Castle PE (2015) Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. Cancer Cytopathol 123, 566 |
62 | Jimenez-Avalos JA, Fernandez-Macias JC and Gonzalez-Palomo AK (2021) Circulating exosomal MicroRNAs: New non-invasive biomarkers of non-communicable disease. Mol Biol Rep 48, 961-967 DOI |
63 | Syrjanen K, Mantyjarvi R, Vayrynen M et al (1987) Human papillomavirus (HPV) infections involved in the neoplastic process of the uterine cervix as established by prospective follow-up of 513 women for two years. Eur J Gynaecol Oncol 8, 5-16 |
64 | Zhao X, Pang L, Qian Y et al (2013) An animal model of buccal mucosa cancer and cervical lymph node metastasis induced by U14 squamous cell carcinoma cells. Exp Ther Med 5, 1083-1088 DOI |
65 | Chen L, Luan S, Xia B et al (2018) Integrated analysis of HPV-mediated immune alterations in cervical cancer. Gynecol Oncol 149, 248-255 DOI |
66 | Lin M, Kim KR anb Ro J (2020) Gastric-type endocervical adenocarcinoma: review of clinicopathologic characteristics and recent advances. J Gynecol Res Obstet 6, 72-75 |
67 | Maru Y, Tanaka N, Ebisawa K et al (2019) Establishment and characterization of patient-derived organoids from a young patient with cervical clear cell carcinoma. Cancer Sci 110, 2992-3005 DOI |
68 | Wu XG, Zhou CF, Zhang YM et al (2019) Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma. Angiogenesis 22, 397-410 DOI |
69 | Lohmussaar K, Boretto M and Clevers H (2020) Humanderived model systems in gynecological cancer research. Trends Cancer 6, 1031-1043 DOI |
70 | Sak K (2014) Characteristic features of cytotoxic activity of flavonoids on human cervical cancer cells. Asian Pac J Cancer Prev 15, 8007-8019 DOI |
71 | Pappa KI, Kontostathi G, Makridakis M et al (2017) High resolution proteomic analysis of the cervical cancer cell lines secretome documents deregulation of multiple proteases. Cancer Genomics Proteomics 14, 507-521 |